Expression of EphA2 is prognostic of disease-free interval and overall survival in surgically treated patients with renal cell carcinoma
Christopher J. Herrem, Tomohide Tatsumi, Kathleen S. Olson, Keisuke Shirai, James H. Finke, Ronald M. Bukowski, Ming Zhou, Amy L. Richmond, Ithaar Derweesh, Michael S. Kinch, Walter J. Storkus
Dive into the research topics of 'Expression of EphA2 is prognostic of disease-free interval and overall survival in surgically treated patients with renal cell carcinoma'. Together they form a unique fingerprint.